BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor (World)
Admedus Completes Fully Subscribed $16.1 Million Rights Issue 4/17/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial 4/16/2015
Nuvo Research Inc. (NRI.TO) Updates Company Strategy 4/16/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Upsizing And Pricing Of Its $60 Million Public Offering Of Ordinary Shares 4/15/2015
WuXi PharmaTech Co., Ltd. Files 2014 Annual Report On Form 20-F 4/15/2015
uniQure (QURE) Announces Pricing Of Follow-On Public Offering 4/10/2015
Cellular Biomedicine Group (CBMG) Upgraded To NASDAQ Global Market 4/10/2015
Resolutions Of The Annual Shareholders’ Meeting Of Sartorius AG 4/9/2015
Replicel Life Sciences Receives TSX Venture Exchange Approval To Extend Warrant Expiry Dates 4/8/2015
Prothena (PRTA) Announces Pricing Of Public Offering Of 3,300,000 Ordinary Shares 4/8/2015
Lonza Group Ltd. (LZAGY.PK) Announces Results Of Annual General Meeting Annual General Meeting Accepts All Motions Proposed By Board Of Directors 4/8/2015
“Batten Down the Hatches” But Look For Opportunity in Rough First Quarter, Says Analyst 4/8/2015
Prothena (PRTA) Announces Proposed Offering of Ordinary Shares 4/7/2015
Teva (TEVA)'s Recent Moves Suggest Restructuring Will Focus on Hypertension, Respiratory & CNS Markets 4/6/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide 4/6/2015
Mallinckrodt (MNK) Launches Notes Offering 4/6/2015
WuXi PharmaTech Co., Ltd. Lists Shares Of Small-Molecule Manufacturing Subsidiary STA On New Third Board In China 4/3/2015
Amgen (AMGN) in the Crosshairs As Biogen (BIIB), Hospira, Merck & Co. (MRK) All Climb on Biosimilar Bandwagon: Citi 4/2/2015
Trinity Biotech plc Announces Proposed Offering Of $100 Million Of Exchangeable Senior Notes Due 2045 4/2/2015
Salix (SLXP) Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes And Merger Event Relating To Its 1.5% Convertible Senior Notes Due 2019 4/2/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Files Registration Statement For Proposed Follow-On Offering 4/2/2015
BTG plc (BTG.L): Close Period Update 4/2/2015
Valeant (VRX) Completes Tender Offer For Salix (SLXP) 4/1/2015
Trillium Therapeutics Inc. Announces Pricing Of Public Offering Of Securities 4/1/2015
Cardio3 BioSciences Announces Intention To Conduct A Registered Public Offering In The United States 4/1/2015
NeuroVive Pharmaceutical AB (publ) - Amendment Number Of Shares And Votes 3/31/2015
Innocoll AG Secures EUR 25 Million Loan Commitment From European Investment Bank (EIB) 3/30/2015
Covalon Technologies Ltd. Announces Issuance Of Stock Options 3/30/2015
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/30/2015
Analyst: First Quarter Market Meltdown Just "Clockwork," As Biogen (BIIB), Celgene (CELG) Reign 3/27/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company 3/27/2015
Why Your Last Investment Blew Up 3/26/2015
Notice of General Meeting In Probi AB (publ) 3/25/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/25/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/24/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY) 3/23/2015
Convening Notice For 2015 Annual General Meeting In Precise Biometrics AB (Publ) 3/23/2015
Notice Of Annual General Meeting In Bioinvent International AB 3/23/2015
TiGenix: Convening Notice To The Annual And The Extraordinary Shareholders' Meeting To Be Held On 20 April 2015 3/20/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/20/2015
Resolutions From The Annual General Meeting Of Novo Nordisk A/S (NVO) 3/19/2015
Admedus Announces Placement And Rights Issue 3/18/2015
MS Specialist Picks Biogen Idec (BIIB)’s Tecfidera and Plegridy, Teva (TEVA)’s Laquinimod: Analyst 3/17/2015
Valeant (VRX) Prices Offering Of $1.45 Billion Of Common Shares 3/17/2015
Valeant (VRX) Announces Offering Of $1.45 Billion Of Common Shares 3/17/2015
Polar Capital Funds Plc And Fmr Llc Provide Notification Of Shareholding In Ablynx (ABLYF) 3/16/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 3/16/2015
Oxford BioMedica PLC (OXB.L) Director's Share Purchase 3/16/2015
Notice of Annual General Meeting Of Orexo AB (ORXOF) 3/16/2015
Ablynx (ABLYF) Announces Warrant Exercise 3/16/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS 3/16/2015
ThromboGenics NV (TBGNF) Full Year 2014 Business Update 3/13/2015
Replicel Life Sciences In Japan For Key Industry Meetings 3/12/2015
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise And Projection Of Improved Cash Position At The End Of 2015 3/12/2015
Actavis (ACT) Announces Closing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/12/2015
Lonza Group Ltd. (LZAGY.PK) Publishes Annual Report 2014 And Invitation To The 2015 Annual General Meeting 3/11/2015
SYGNIS AG To Host Live Webinar On Its Revolutionary TrueprimeTechnology For Primer-Free Whole Genome Amplification (WGA) 3/11/2015
Valeant (VRX) Announces Launch Of Private Offering Of Senior Notes 3/10/2015
Horizon Pharma plc.  (HZNP) Prices Offering Of $350 Million Of 2.50% Exchangeable Senior Notes 3/9/2015
BioLineRx Ltd. Announces Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
AEterna Zentaris (AEZS) Announces Pricing Of US$37 Million Public Offering Of Common Shares And Warrants 3/6/2015
Galapagos NV (GLPG.BR) To Be Included In Amsterdam Midcap Index 3/6/2015
PhytoTech Medical Limited (ASX:PYL) Investor Presentation 3/6/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst 3/6/2015
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib 3/5/2015
Actavis (ACT) Announces Pricing Of Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/4/2015
Neovacs SA Scientific Advisory Board Endorses Company's Updated IFNa-Kinoid Development Plan 3/4/2015
Actavis (ACT) Announces Closing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 3/3/2015
Mylan Inc. (MYL) Files Annual Report On Form 10-K For Year Ended Dec. 31, 2014 3/3/2015
Aviva Plc And Aviva Investors Global Services Limited Provide Notification Of A 5.02% Shareholding In Ablynx (ABLYF) 3/3/2015
Alnylam (ALNY)’s “Incredibly Deep” Pipeline Continues to Impress As Commercial Stage Looms, Says Analyst 3/2/2015
Karolinska Development AB Confirms Full Payment In The Rights Issue Of Convertibles 3/2/2015
Actavis (ACT) Announces Proposed Public Offering Of Senior Notes In Connection With Pending Acquisition Of Allergan (AGN) 3/2/2015
InMed To Present Investor Webcast March 5 3/2/2015
Tianyin Pharmaceutical Co, Inc. Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 2/27/2015
Teva Pharmaceutical Industries (TEVA) Announces Early Results Of Debt Tender Offer, Pricing, Election Of Early Settlement And Increase In Maximum Amount And Priority 2 Notes Tender Cap 2/27/2015
Presentation Of The Result Of Medivir AB (MVRBF)’s Voluntary Redemption Programme 2/27/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 2/27/2015
Cardio3 BioSciences To Raise Capital Via A Private Placement Of New Shares 2/26/2015
Actavis (ACT) Announces Pricing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 2/25/2015
Alkermes plc (ALKS) Announces Webcast Of Analyst And Investor Event On March 2, 2015 2/24/2015
GENFIT Corp. (ALGFT): Minutes Of The Combined General Shareholders' Meeting Of February 24, 2015 2/24/2015
Fake Quote Scandal: Medical Marijuana Firm CEN Biotech Receives Major Setback 2/20/2015
RedHill Biopharma Ltd. (RDHL) Announces Full Exercise Of Underwriters' Over-Allotment Option 2/18/2015
RedHill Biopharma Ltd. (RDHL) Announces Closing Of Public Offering Of Its American Depository Shares 2/13/2015
VolitionRX Announces Closing Of Public Offering Of Common Stock 2/12/2015
Transition Therapeutics Inc. (TTH.TO) Announces Pricing Of Public Offering Of US$20 Million Of Common Shares 2/12/2015
BIOCEO15: Kite Pharma (KITE) Debuts Near-Term Plans, Says It’s Tackling "Toxicity Issues" 2/10/2015
BIOCEO15: New Report On Biotech Venture Capital Over Last 10 Years Finds Heavy Focus on R&D 2/10/2015
BIOCEO15: Sarepta (SRPT) CEO Feels Backlash After Saying Ebola Research Isn’t in "Shareholder Interest" 2/10/2015
RedHill Biopharma Ltd. (RDHL) Prices Public Offering Of Its American Depository Shares 2/10/2015
RedHill Biopharma Ltd. (RDHL) Announces Proposed Public Offering Of Its American Depository Shares 2/10/2015
Suven Life Sciences Ltd Revenue Growth At 9% While PAT Is Down By 11.55% For The 3rd Quarter Ended Dec 2014 2/10/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
BNP Paribas Notify Of 5.08% Shareholding In Galapagos NV (GLPG.BR) 2/9/2015
VolitionRX Prices Public Offering of Common Stock 2/6/2015
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 2/5/2015
Express Scripts Inc. Cheers As Data Shows Drug Pricing Up 3-Fold, Even When Adjusted For Inflation, Survival 2/5/2015
Macrocure (MCUR) Announces Special General Meeting Of Shareholders For Approval Of Amendments To Compensation Package Of CEO And 2013 Share Incentive Plan 2/5/2015
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At Two Upcoming Conferences 2/4/2015
Forget Smartphones—Genomic Data is the Next Big Deal, Says Edico Genome CEO 2/4/2015
Summit Corporation Files Registration Statement For Proposed U.S. Public Offering And Applies For NASDAQ Listing 2/2/2015
Admedus Release: Announcement To The Australian Stock Exchange 2/2/2015
Oxford Immunotec Limited (OXFD) Announces Proposed Underwritten Offering Of Ordinary Shares 1/29/2015
Future Of Healthcare Investor Forum Highlights Investment Opportunity In UK Life Sciences 1/29/2015
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK) 1/28/2015
Ascendis Pharma A/S Announces Pricing Of Initial Public Offering 1/28/2015
ESSA Pharma Inc. Lists On The TSX Venture Exchange 1/28/2015
AnaMar Announces Strategic Realignment And 2015 Corporate Priorities 1/28/2015
Oxford Immunotec Global PLC Announces Proposed Underwritten Offering Of Ordinary Shares 1/28/2015
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China 1/27/2015
Amgen (AMGN) Beats Street’s Earnings Estimates, Ready for Biosimilars, Says Citi 1/27/2015
Cortendo AB: Notification Of Trade 1/27/2015
Medivir AB (MVRBF)’s CEO Increases His Shareholding In The Company 1/27/2015
Ultimovacs Carries Out NOK 45 Million Share Issue With Canica AS And Sundt AS As The Main Investors 1/22/2015
Ablynx (ABLYF) Announces Warrant Exercise 1/21/2015
Endo International (ENDP) Announces Pricing of Private Offering Of Senior Notes 1/21/2015
Endo International (ENDP) Announces Proposed Private Offering Of Senior Notes 1/20/2015
NeuroDerm Ltd. (NDRM) Announces Extraordinary General Meeting Of Shareholders For Ratification Of Election Of External Directors And Adoption Of Compensation Policy 1/20/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 1/20/2015
Horizon Discovery Group plc Trading Update 1/19/2015
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 1/16/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 1/15/2015
Alcobra (ADHD) Announces Closing Of Public Offering Of Ordinary Shares And Full Exercise Of Over-Allotment Option 1/14/2015
Debiopharm Diagnostics Leads Investment Round In GenePOC With Emerillon Capital 1/14/2015
ProSensa Holding N.V. (RNA) Announces Shareholder Approval Of Certain Matters Relating To The BioMarin (BMRN) Tender Offer 1/13/2015
Cardio3 BioSciences To Host Investor & Analyst Day In New York On Friday, January 30, 2015 1/13/2015
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 1/12/2015
MGB Biopharma Limited Continues To Progress Its Truly Novel Anti-Infectives Platform To Tackle Antibiotic Resistance In 2014 1/12/2015
Allergy Therapeutics plc Release: Trading Update 1/12/2015
Skyepharma PLC (SKYEF) Release: Pre-Close Update 1/12/2015
ERYtech Pharma Announces ADR Level 1 Listing In The U.S. 1/12/2015
Fountain Healthcare's New €85 Million Fund to Create New Jobs in Biotech, Medtech 1/9/2015
Alcobra (ADHD) Announces Commencement Of Public Offering Of Ordinary Shares 1/9/2015
Alcobra (ADHD) Prices Public Offering Of Ordinary Shares 1/9/2015
China Biologic Products Adopts Stockholder Rights Plan 1/9/2015
Seventure Invests EUR 1 M (USD 1.25 M) In First Investment Round For MaaT Pharma™ 1/9/2015
EXCLUSIVE: Developing World Needs Different Pricing Model, Naia Limited CEO Tells BioSpace (DHX) 1/9/2015
TRANSGENE (ENX:TNG) Announces Financial Calendar For 2015 1/8/2015
Fundamentals Still Strong for Large Cap Biotech, But Headwinds Remain 1/7/2015
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 1/6/2015
The FDA’s Breakthrough Therapy Program By the Numbers 1/5/2015
Protalix Biotherapeutics, Inc. (PLX) Announces New Strategy For Accelerated Growth 1/5/2015
RedHill Biopharma Ltd. (RDHL) Business Outlook And Anticipated Key Milestones For 2015 1/5/2015
Enzymotec Announces An Extraordinary General Meeting Of Shareholders 1/5/2015
Biotech Investors Surge Happily Into New Year, “Frothy” or Not, Says Cowen 1/5/2015
Tianyin Pharmaceutical Co, Inc. Updates on Alliance Discussion 1/2/2015
AmpliPhi Biosciences Corporation (APHB) To Host Shareholder Update Conference Call 12/31/2014
Share Buybacks Could Save Gilead Sciences, Inc. (GILD) After Turbulent Two Weeks, Says Citi 12/30/2014
Change Of Number Of Shares And Votes In Karolinska Development AB 12/30/2014
Change In Number Of Shares And Votes In Meda AB (MEDA-A.ST) 12/30/2014
Bloodbath On Wall Street Over Drug Pricing Will Taper, Says Analyst 12/23/2014
AbbVie (ABBV)’s Access to Express Scripts Inc. a “Pyrrhic Victory,” Says Analyst 12/22/2014
Covidien plc (COV) Declares Quarterly Cash Dividend 12/22/2014
GlaxoSmithKline (GSK) Reassure Investors That Dividend Is Safe As Analysts Question Payout 12/19/2014
AEterna Zentaris (AEZS) Receives Notification From NASDAQ Relating To Minimum Bid Price 12/19/2014
Biotech Predictions for Large Cap Firms Include Medivation, Inc. (MDVN), Gilead Sciences, Inc. (GILD) 12/18/2014
2015 Could Be Blockbuster Year for Alkermes plc (ALKS), Says Citi 12/17/2014
K-Bro Declares December Dividend 12/16/2014
The Biotech Year in Review, According To Bernstein 12/16/2014
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting 12/11/2014
Analysts Not Sold On Medivation, Inc. (MDVN)’s Xtandi as Breast Cancer Drug 12/10/2014
bluebird bio (BLUE)’s New Blood Treatment Could Benefit Sickle Cell, Says Analyst 12/9/2014
Karolinska Development AB Release: Purchase Of Own Shares To Cover Social Security Fees Related To Incentive Program 12/8/2014
Survey of Investors, Hedge Funds Blasé on Merck & Co. (MRK), Cubist Pharmaceuticals, Inc. (CBST) Deal 12/8/2014
Rubicon Hints At ArborGen IPO, Laments Skidding Share Price 12/5/2014
Drug Spending Still Under 10% of American Health Costs, Says Analyst 12/5/2014
GlaxoSmithKline (GSK) Abandons Planned Sale Of Established Products Portfolio 12/5/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
WuXi PharmaTech Co., Ltd. Subsidiary Submits Application To The National Equities Exchange And Quotations In China To List On The New Third Board 12/4/2014
BTG plc (BTG.L) Results Of Placing 12/4/2014
Perrigo Company (PRGO) Announces The Closing Of Its Registered Public Offering Of Senior Notes 12/3/2014
DelMar Pharmaceuticals Joins OTCQX 12/3/2014
Is New Alzheimer’s Drug the Stabilizing Force Biogen Idec (BIIB) Needs? 12/3/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
Teva Pharmaceutical Industries Limited (TEVA) To Host 2015 Business Outlook Conference Call And Webcast On December 11, 2014 12/2/2014
Valeant (VRX) Announces Redemption Of US$445.0 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 12/1/2014
Immune Pharmaceuticals, Inc. Completes Underwriter's Exercise Of Partial Over-Allotment Option 12/1/2014
Roche Holdings, Inc. Announces Final Results Of Its Debt Tender Offer 12/1/2014
2015 Will Be A Defining Year for Gene Therapy, Says Analyst 12/1/2014
Cowen: With NASDAQ Index Up 33%, Biotech Remains a Winner 12/1/2014
e-Therapeutics plc Release: Research And Development Presentation To Investors And Analysts 12/1/2014
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 11/26/2014
Cynapsus Therapeutics (CYNAF) Announces Uplisting To The Toronto Stock Exchange’s Senior Equity Market 11/26/2014
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At The NASDAQ OMX 31st Investor Program 11/26/2014
Immune Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 11/26/2014
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014
Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc 11/25/2014
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014
Tekmira (TKMR) Provides Key Highlights Of Analyst And Investor Day In New York 11/24/2014
Bayer AG (BAYZF) To Use IPO Funds To Cut Debt And Buy Consumer Drugs 11/24/2014
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme (EPZM), Says Citi 11/21/2014
Perrigo Company Plc Announces The Pricing Of Its Offering Of Ordinary Shares 11/21/2014
uniQure To Host Investor Day In New York City 11/21/2014
Cowen: Acorda Therapeutics (ACOR) Not Worried About Civitas Therapeutics' New Parkinson's Drug 11/20/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst 11/19/2014
Best Value In Biotech? Actavis (ACT), Says UBS 11/17/2014
Forward Pharma (FWP) Announces Closing Of Partial Exercise Of Over-Allotment Option 11/17/2014